HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

101 oesophageal cancers: a surgeon uses radiotherapy.

Abstract
One hundred and one consecutive patients with oesophageal cancer, cancer of the cardia and gastric cancer extending upwards from the stomach to the oesophagus were treated from 1979 to 1985 with a policy that included radiotherapy treatment for 58. This heterogeneous group, which was considered together as oesophageal cancer, was subdivided according to anatomical location, histology and pretreatment staging. Those patients who could be treated surgically by a resection and anastomosis performed below the diaphragm were excluded. Thirty-five had surgery which was either an oesophagogastrectomy or oesophagojejunostomy with an intrathoracic anastomosis, except for two who were nonresectable. Eight patients were to ill or refused treatment. The role of radiotherapy was assessed in three groups: i. Operable squamous cell carcinoma of the oesophagus was treated by radical radiotherapy (22) with a 46% 1-year and 14% 5-year survival. ii. Inoperable squamous cell carcinoma of the oesophagus was given radical or palliative radiotherapy (25) with a 16% 1-year and 4% 5-year survival. iii. Non-resectable adenocarcinoma of the stomach or oesophagus was treated palliatively by radiotherapy to debulk the intraluminal tumour (11), all of whom had symptomatic relief of dysphagia. The results of radical radiotherapy for operable squamous cell carcinoma of the oesophagus were similar to the best results achieved by surgical resection in other series in which there is comparable staging. Radiotherapy should be included in the treatment options for oesophageal cancer.
AuthorsR J Earlam, L Johnson
JournalAnnals of the Royal College of Surgeons of England (Ann R Coll Surg Engl) Vol. 72 Issue 1 Pg. 32-40 (Jan 1990) ISSN: 0035-8843 [Print] England
PMID1689132 (Publication Type: Journal Article)
Topics
  • Adenocarcinoma (mortality, radiotherapy)
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell (mortality, radiotherapy)
  • Cardia
  • Combined Modality Therapy
  • Dilatation
  • Esophageal Neoplasms (mortality, radiotherapy)
  • Follow-Up Studies
  • Humans
  • Intubation
  • Middle Aged
  • Neoplasm Staging
  • Palliative Care
  • Stomach Neoplasms (mortality, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: